If used, solutions containing particulate matter could possibly block blood vessels and cause a stroke, heart attack or organ damage, according to the news release.
Affected lots were distributed to customers between May 2012 and October 2013.
The specific recalled lots are listed on the news release.
More Article on Medical Recalls:
Hospira Voluntarily Recalls One Lot of Lidocaine HCl Injection
Abrams Royal Pharmacy Recalls All Unexpired Sterile Products
Alexion Pharmaceuticals Updates Soliris Recall Information
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
